Board Structure
Composition of the BOD
The board of directors is composed of seven members consisting of three directors and four independent directors. Independent directors have no ties to the company either through transactions or as a former employee or inside director.
-
- President & CEO,
Chairman of the board - John Rim
- President & CEO, Samsung Biologics (2020-Present)
- Executive Vice President, CMO2 Center,
Samsung Biologics (2018-2020) - Vice President, Global Product Development Procurement, Roche (2014-2018)
- Vice President, CFO Global Product Development, Roche (2010-2013)
- Date of first appointment : March 20, 2020
- Term expiration : March 16, 2026
- President & CEO,
-
- EXECUTIVE VICE PRESIDENT
- Dong Joong Kim
- Executive Vice President,
Business Support Center, Samsung Biologics (2014-Present) - Head of Planning Support Team,
Production Technology Institute,
Samsung Electronics(2013-2014)
- Date of first appointment : August 10, 2016
- Term expiration : March 28, 2025
-
- EXECUTIVE VICE PRESIDENT
- Kun Lo
- Executive Vice President,
EPCV Center, Samsung Biologics(2021~Present) - Head of DS Center, Samsung Biologics(2020~2021)
- Head of New Business Division, Samsung Engineering(2013~2020)
- Date of first appointment : March 17, 2023
- Term expiration : March 16, 2026
-
- Independent Director
- Geunnyeong Heo
- Independent Director,
Samsung Biologics(2019-Present) - Advisor, Pyeong An Lawfirm(2019-Present)
- Presiding Judge,
Seoul Central District Court (2004-2007)
- Date of first appointment : March 22, 2019
- Term expiration : March 28, 2025
-
- Independent Director
-
Eunice Kyonghee Kim
- Independent Director, Samsung Biologics (2020-Present)
- Professor, Law School, Ewha Women's University (2010-2021)
- Vice president, International Association of Korean Lawyers (IAKL) (2008-Present)
- Deputy-CEO and Chief Legal & Compliance Officer, Hana Financial Group, Inc. (2008-2010)
- Date of first appointment : March 20, 2020
- Term expiration : March 16, 2026
-
- Independent Director
- Changwoo Lee
- Independent Director, Samsung Biologics(2022-Present)
- Emeritus Faculty, Business School,
Seoul National University(2019-Present) - Chairman of the Ethics Committee,
Korean Accounting Standard Board(2020-Present)
- Date of first appointment : March 29, 2022
- Term expiration : March 28, 2025
-
- Independent Director
- Seoung Hwan Suh
- Current Professor Emeritus at Yonsei University(2024-Present)
- 19th President, Yonsei University(2020-2024)
- Minister for Ministry of Land, Infrastructure, and Transport(2013-2015)
- 18th Korea Presidential Transition Committee, Committee Member of the Economics Division 2(2013)
- Date of first appointment : March 15, 2024
- Term expiration : March 14, 2027
Appointment of Directors
Members of the board of directors are elected through a resolution of the general meeting of shareholders under the company’s articles of incorporation. Incumbent members may be reelected after the expiration of their terms.
- Samsung Biologics shall have at least three but no more than ten directors and such directors shall be appointed at the general meeting of shareholders; provided, however, that at least three independent directors shall be appointed and the number of the independent directors shall account for at least a majority of the total number of directors.
- A resolution for the election of directors shall be adopted by the affirmative votes of a majority of the shareholders present at the meeting, which shall also be at least 1/4 of the total number of issued and outstanding shares.
- Any vacancy in the office of directors shall be filled at a general meeting of shareholders; provided, however, that if the number of directors does not fall below the number prescribed in Paragraph 1 of Article 29 in the Articles of Incorporation and there is no difficulty in the administration of business, the foregoing shall not be applicable.
Term of Office of Director
The term of office of directors shall end at the close of the ordinary general meeting of shareholders convened in respect to the last fiscal year within three years from their appointment.
Chairperson
The chairperson of the board of directors shall be appointed among the directors by a resolution of the board of directors.
Resolution of the BOD
The resolution of the board of directors shall be adopted in the attendance of a majority of the directors in the office and by the affirmative votes of a majority of the directors present at the meeting; provided, however, that a resolution of the board of directors on matters stipulated under Article 397-2 (Prohibition of Use of Corporate Opportunities and Assets) and Article 398 (Self-Dealing between Directors, etc. and the Company) of the Commercial Code shall be adopted by the affirmative votes of at least 2/3 of the directors in office.
Independence of Independent Directors
The Independent Director Candidate Nomination Committee shall nominate the candidates for the independent directors among persons who meet qualification requirements stipulated in the relevant laws and regulations, including the Commercial Code, etc.
- An independent director shall be one with professional knowledge or sufficient experience in management, economics, accounting, law or relevant technology and duly qualified under the relevant law. He or she shall not be a current employee or director or a previous employee or director of the company or its affiliate (as stipulated in the Monopoly Regulation and Fair Trade Act) within the past two years, a major shareholder of the company or one with a special relationship with a major shareholder.
Operation and Duties
The board of directors shall be divided into an ordinary and extraordinary board.
In principle the chairperson convenes the board of directors meeting, and if it is deemed necessary for administration of business, any director may convene the board of directors meeting with the consent of the chairperson.
Meetings of the BOD
The board of directors shall be divided into an ordinary and extraordinary board.
- Ordinary Board of Directors : The meeting of ordinary board of directors is held once a quarter. The chairperson of the board of directors shall set the date and call for the meeting.
- Extraordinary Board of Directors : The meeting of extraordinary board of directors may be held from time to time as required.
Convening of BOD Meeting
In principle the chairperson convenes the board of directors meeting, and if it is deemed necessary for administration of business, any director may convene the board of directors meeting with the consent of the chairperson.
- Procedure : The chairperson shall set a date and time of the meeting of the board of directors and give a notice to each director no later than twenty four hours prior to the meeting in writing, electronic document, or orally; provided, however, that such notice may be waived with the unanimous consent of all directors.
Resolution of the BOD
The resolution of the board of directors shall be adopted in the attendance of a majority of the directors in office and by the affirmative votes of a majority of the directors present at the meeting.
- The board of directors may allow all or a part of the directors who do not attend a meeting in person to participate in a resolution through communication that concurrently transmits and receives voices of all directors. In this case, such director shall be deemed to have attended the board of directors meeting in person.
- A director with his or her own interests in a resolution of the board of directors shall not be allowed to participate in voting.
BOD Operation Rules
- Article 1Purpose
- Article 2Scope of Applications
-
- With respect to matters pertaining to the BOD, these rules and regulations shall apply unless those stipulated otherwise in the relevant laws or the AOI.
- Article 3Authority
-
- ①The BOD shall deliberate and resolve matters stipulated in the relevant laws or the AOI, matters authorized by the general meeting of shareholders, and important issues concerning basic policies and execution of business related to the management of the Company.
- ②The BOD shall supervise the directors’ execution of duty.
- ③When it is determined that a director has violated a provision of the laws or the AOI in performing his/her duties, or performed such duties in a substantially improper manner, or the BOD recognizes that there is a concern that such director will perform his/ her duties in a substantially improper manner, the BOD may request such director to submit relevant data, cooperate on investigation, and/or provide explanation.
- ④If any of the events in Paragraph 3 occurs, the BOD may require the relevant director to suspend or change the performance of relevant duties.
- ⑤Any director may request the representative director to report performance of other directors or employees to the BOD.
- Article 4Composition
-
- ①The BOD shall be comprised of all directors.
- ②The term of office of a director shall expire at the close of the ordinary general meeting of shareholders held for the third fiscal period from the inauguration of the applicable director.
- Article 5Chairperson
-
- ①The chairperson of the BOD shall be appointed among the directors by a resolution of the BOD.
- ②The term of office of the chairperson shall end at the expiration of the term of office of the applicable director.
- ③When the chairperson is unable to perform his/her duties, the director that was first appointed among all of the directors of the BOD shall act as the chairperson; provided, however, that if two (2) or more directors were appointed on the same date, the most senior director shall act as the chairperson.
- Article 6Convening of BOD Meeting
-
- ①The meetings of the BOD shall be either ordinary meetings or extraordinary meetings.
- ②Ordinary meetings of the BOD shall, in principle, be convened once each quarter.
- ③Extraordinary meetings of the BOD shall be convened on an ad-hoc basis when deemed necessary.
- ④The chairperson of the BOD shall set a date and time of the meeting of the BOD, and provide written, electronic, or oral notice to each director no later than 24 hours in advance of such meeting; provided, however, that such convocation procedure may be omitted upon unanimous consent of the directors.
- ⑤If it is deemed necessary for carrying out the business of the Company, any director may convene a meeting of the BOD upon the consent of the chairperson. In this case, the provisions in Paragraph 4 above shall apply mutatis mutandis.
- Article 7Method of Resolution
-
- ①Unless stipulated otherwise in the relevant laws and regulations, the BOD resolutions shall be done in accordance with Paragraphs 1 through 3 of Article 38 of the AOI.
- ②Unless stipulated otherwise in the relevant laws and regulations, the number of directors who cannot exercise his/her vote in accordance with Article 38, Paragraph 3 of the AOI shall not be included in the number of directors present at the meeting.
- Article 8Agenda
-
-
①The following matters shall be resolved by the BOD:
-
1.Convening of the general meeting of shareholders and matters for resolution to be submitted thereto
【Mandatory agenda items set forth in the relevant laws/regulations and the AOI】
- 1)Convening of the general meeting of shareholders
- 2)Approval of financial statements
- 3)Approval of annual report
- 4)Distribution of profits
- 5)Amendment to the AOI
- 6)Capital reduction
- 7)Dissolution, amalgamation, spin-off, merger through spin-off, continuation of company (Article 519 of the Commercial Code)
- 8)Assignment of the businesses of the Company in whole or in material part; acquisition in whole or in part of another company’s business having a material impact on the business of the Company
- 9)Lease or entrustment of management business in whole; execution of contract where all profits and losses are shared with a 3rd party (each a “Shared Contract”); execution, amendment, or termination of another contract that is commensurate to a Shared Contract
- 10)Ex-post incorporation
- 11)Appointment and dismissal of directors
- 12)Remuneration of directors
- 13)Issuance of shares at less-than-face value
- 14)Acquisition of treasury shares
- 15)Decision on stock dividends
- 16)Stock-split and stock-consolidation of shares
- 17)Waiver of a director’s liability toward the Company upon unanimous consent of the shareholders
- 18)Redemption of shares
- 19)Total share swap
- 20)Total share transfer
- 21)Granting of stock options
- 22)Other agenda items to be submitted to the general meeting of shareholders and material issues concerning shares
-
2.Matters pertaining to management
【Mandatory agenda items set forth in the relevant laws/regulations and the AOI】
- 1)Decision on short form merger, short form merger through spin-off, small-scale mergers, and small-scale merger through spin-off
- 2)Execution and reporting of asset revaluation
【Other important matters pertaining to the management of the Company】- 1)Establishment and revision of basic policies on the management of the Company
-
3.Matters pertaining to finance
【Mandatory agenda items set forth in the relevant laws/regulations and the AOI】
- 1)Disposition or redemption of treasury shares
- 2)Issuance of new shares
- 3)Issuance of corporate bonds, convertible bonds, or bonds with warrants
- 4)Capitalization of reserves
- 5)Allocation of new shares to a 3rd party
- 6)Distribution of interim dividends
- 7)Transaction with a “specially-related party” as set forth in the Commercial Code or large-scale transaction for a “specially-related party”
- 8)Handling of forfeited shares in case of capitalization by issuing new shares
【Other important matters pertaining to finance】- 1)Foreign direct investment valued at 2.5% or more of the equity capital of the Company
- 2)Listing of shares or depository certificates in a foreign stock exchange
- 3)Borrowing valued at 2.5% or more of the equity capital of the Company
- 4)Acquisition or waiver of debt valued at 2.5% or more of the equity capital of the Company per transaction
- 5)Offering of security or guarantee of debt valued at 2.5% or more of the equity capital of the Company per transaction
- 6)Donation or sponsorship valued at KRW 100 million or more
- 7)Other important financial matters to be submitted to the BOD
-
4.Matters pertaining to directors, the BOD, committees, etc.
【Mandatory agenda items set forth in the relevant laws/regulations and the AOI】
- 1)Appointment of the representative director
- 2)Appointment of the chairperson of the BOD in case the representative director is unable to serve as the chairperson
- 3)Establishment and operation of a committee(s) within the BOD, appointment and dismissal of a committee member
- 4)Approval of a director serving as a concurrent director at another company that competes with or operates in the same industry as the Company and approval of transaction between a director, etc., and the Company
- 5)Re-resolution of an agenda item for resolution by a committee within the BOD
- 6)Appointment or dismissal of a director from a specific position or duty
【Other important matters pertaining to directors, the BOD, committees, etc.】- 1)Enforcement or nullification of the Rules and Regulations of the Board of Directors or the rules and regulations of committees within the BOD (operational guidelines)
-
5.Others
- 1)Other matters set forth in the relevant laws and regulations or the AOI, authorized and delegated by the general meeting of shareholders, or deemed necessary by the representative director
-
1.Convening of the general meeting of shareholders and matters for resolution to be submitted thereto
-
②The following matters shall be reported to the BOD:
- 1.Matters that have been delegated to a committee(s) within the BOD and how such matters were decided / resolved
- 2.Matters for which the Audit Committee has determined that a director has or there is a concern that a director may violate the relevant laws or the AOI
- 3.Other matters pertaining to the execution of matters that are considered important to the operations of the Company
-
①The following matters shall be resolved by the BOD:
- Article 9Delegation of Authority
-
- Unless stipulated otherwise in the relevant laws and regulations or the AOI, the representative director or a committee authorized by the BOD under Article 10 may be delegated with the authority to make decisions on matters that require a resolution of the BOD.
- Article 10Committees under BOD
-
- ①Committees within the BOD shall be subject to Article 37 of the AOI; provided, however, that with respect to the Audit Committee, Chapter 6 (Audit Committee) of the AOI shall first apply.
- ②The Management Committee shall operate in compliance with the rules and resolutions of the BOD, and in addition, deliberate on and resolve matters delegated by the BOD from time to time.
- ③Unless they are in conflict with Paragraph 1 of this Article 10 and the rules of applicable committee within the BOD, Article 38 of the AOI shall apply mutatis mutandis to the committee(s) within the BOD. In such provisions of the AOI, “BOD” shall mean applicable “committee within the BOD” and “Director” shall mean a “member of such committee.”
- ④Notwithstanding anything stated in Paragraph 3 of Article 10, matters set forth in Article 397-2 (Restriction on Abuse of Corporate Opportunities and Assets of the Company) and Article 398 (Transactions between Directors, Etc., and the Company) of the Commercial Code shall be adopted by two-thirds or more of the registered directors of the BOD.
- Article 11Counsel of Relevant Persons
-
- ①In deliberating on an agenda item, the BOD may invite a relevant officer or employee of the Company or a third party to attend the BOD meeting and explain the agenda item or provide his/her opinion.
- ②The BOD may, at the cost of the Company, resolve to engage an expert or other similar individual to consult on a particular agenda item, if it finds such a service necessary.
- Article 12Meeting Minutes
-
- Meeting minutes shall be prepared for BOD meetings and meetings of any committee within the BOD, and such meeting minutes shall set forth the agenda, proceedings of the meeting, results, objecting party and reason(s) for objection, and be affixed with the seal impressions of or signed by the directors present at the meeting.
- Article 13Ratification
-
- If an issue is urgent, and there is insufficient time to convene a meeting of the BOD, so long as and to the extent it does not violate the relevant laws and regulations, the representative director shall perform the necessary action and convene a meeting of the BOD after the fact where he/she shall report the progress of such action and obtain the BOD’s ratification.
- Article 14Secretary
-
- ①The BOD shall have a secretary who shall be appointed by the chairperson.
- ②The chairperson of the BOD shall instruct and supervise the secretary. The secretary shall assist each director of the BOD and administer the overall operations of the BOD.
- Article 15Expenses
-
- Expenses necessary for meetings and other operations shall be borne by the Company.
- Article 16Enactment and Nullification of the Rules
-
- These Rules shall be enacted and nullified by a resolution of the BOD.
- Addendum
-
- Article 1 (Effective Date)
- These Rules shall become effective on August 10, 2016.
Major Agenda items
1. A director with his or her own interests in a resolution of the board of directors shall not be allowed to participate in voting.
- Convening of the general meeting of shareholders
- Approval of financial statements
- Approval of annual report
- Amendment to the AOI
- Dissolution, amalgamation, continuation of company
- Assignment of the businesses of the company in whole or in material part; acquisition in whole or in part of another company’s business having a material impact on the business of the company.
- Appointment and dismissal of directors
- Remuneration of directors, etc.
2. Matters pertaining to management
- Matters pertaining to management
- Enforcement or nullification of the Rules and Regulations of the Board of Directors or the rules and regulations of committees within the BOD
3. Matters pertaining to finance
- Disposition or redemption of treasury shares
- issuance of new shares
- Issuance of corporate bonds, convertible bonds, or bonds with warrants
- Foreign direct investment, borrowing, acquisition or waiver of debt, offering of security or guarantee of debt, etc.
- Transaction with a “specially-related party” as set forth in the Commercial Code or large-scale transaction for a “specially-related party”, etc.
- Donation or sponsorship
4. Matters pertaining to directors, the BOD, committees, etc.
- Appointment of the representative director
- Appointment of the chairperson of the BOD
- Approval of a director serving as a concurrent director at another company that competes with or operates in the same industry as the Samsung iologics and approval of transaction between a director, etc., and Samsung Biologics
- Appoint or dismissal of a director from a specific position or duty
5. Others
- Other matters set forth in the relevant laws and regulations or the AOI, authorized and delegatedby the general meeting of shareholders, or deemed necessary by the representative director
Activity of the BOD
Activity of the BOD includes the status of the board of directors' activities such as appointment, commissioning, approval, participation, decision, revision, enforcement, reporting and issuance.
2023
| Date | Agenda | Result | Attendance |
|---|---|---|---|
| DEC. 20, 2023 | (Reported) 2023 Employee incentive provision plan | - | 7/7 |
| 1. Approval of transactions with major shareholders | Approved | ||
| 2. Approval of transactions with related parties | Approved | ||
| 3. Amendments on operation policy of Board of Directors | Approved | ||
| 4. Appointment of lead independent director | Approved | ||
| 5. Approval of charity donation | Approved | ||
| 6. Nomination of Board of Director's committee members | Approved | ||
| OCT. 25, 2023 | (Reported) 3Q 2023 interim business result | - | 7/7 |
| 1. Approval of purchasing package insurance from Samsung Fire & Marine Insurance Co.,Ltd | Approved | ||
| 2. Approval of New Technology Investment Association | Approved | ||
| 3. Approval of investment in construction of ADC facility | Approved | ||
| 4. Approval of transactions with related parties | Approved | ||
| 5. Appointment of internal compliance auditor | Approved | ||
| JUL. 26, 2023 | (Reported) 1H 2023 interim business result | - | 7/7 |
| (Reported) Report on increased legal fees and expenses associated with the accounting lawsuit | - | ||
| 1. Approval of transactions with major shareholders | Approved | ||
| 2. Regulation of responsibility and authority for Chief Safety Officer (CSO) | Approved | ||
| APR. 24, 2023 | (Reported) 1Q 2023 interim business result | - | 7/7 |
| (Reported) 2023 ESG management plan | - | ||
| 1. Approval of transactions with major shareholders | Approved | ||
| MAR. 17, 2023 | (Reported) Progress on important matters | - | 6/7 |
| (Reported) 2023 health and safety plan | - | ||
| 1. Nomination of Chief Executive Officer | Approved | ||
| 2. Nomination of Board of Director’s chairman | Approved | ||
| 3. Nomination of Board of Director's committeemembers | Approved | ||
| 4. Review of compensation for directors | Approved | ||
| 5. Approval of transactions with related parties | Approved | ||
| 6. Approval of investment for Plant 5 construction | Approved | ||
| FEB. 15, 2023 | (Reported) Operation status of internal control over financial reporting | - | 5/6 |
| (Reported) Assessment on internal control over financial reporting and audit report | - | ||
| (Reported) 2022 audit performance report | - | ||
| 1. Approval of amendments to internal control management | Approved | ||
| 2. Approval of convocation and objectives of general meetings of shareholders | Approved | ||
| JAN. 27, 2023 | (Reported) Progress on important matters | - | 6/6 |
| 1. Approval of FY2022 financial statements, annual business report, and 2023 business plan | Approved | ||
| 2. Approval of transactions with related parties | Approved |
|
DEC. 20, 2023 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) 2023 Employee incentive provision plan |
| Result | - |
| Agenda | 1. Approval of transactions with major shareholders |
| Result | Approved |
| Agenda | 2. Approval of transactions with related parties |
| Result | Approved |
| Agenda | 3. Amendments on operation policy of Board of Directors |
| Result | Approved |
| Agenda | 4. Appointment of lead independent director |
| Result | Approved |
| Agenda | 5. Approval of charity donation |
| Result | Approved |
| Agenda | 6. Nomination of Board of Director's committee members |
| Result | Approved |
|
OCT. 25, 2023 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) 3Q 2023 interim business result |
| Result | - |
| Agenda | 1. Approval of purchasing package insurance from Samsung Fire & Marine Insurance Co.,Ltd |
| Result | Approved |
| Agenda | 2. Approval of New Technology Investment Association |
| Result | Approved |
| Agenda | 3. Approval of investment in construction of ADC facility |
| Result | Approved |
| Agenda | 4. Approval of transactions with related parties |
| Result | Approved |
| Agenda | 5. Appointment of internal compliance auditor |
| Result | Approved |
|
JUL. 26, 2023 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) 1H 2023 interim business result |
| Result | - |
| Agenda | (Reported) Report on increased legal fees and expenses associated with the accounting lawsuit |
| Result | - |
| Agenda | 1. Approval of transactions with major shareholders |
| Result | Approved |
| Agenda | 2. Regulation of responsibility and authority for Chief Safety Officer (CSO) |
| Result | Approved |
|
APR. 24, 2023 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) 1Q 2023 interim business result |
| Result | - |
| Agenda | (Reported) 2023 ESG management plan |
| Result | - |
| Agenda | 1. Approval of transactions with major shareholders |
| Result | Approved |
|
MAR. 17, 2023 Attendance 6/7
|
|
|---|---|
| Agenda | (Reported) Progress on important matters |
| Result | - |
| Agenda | (Reported) 2023 health and safety plan |
| Result | - |
| Agenda | 1. Nomination of Chief Executive Officer |
| Result | Approved |
| Agenda | 2. Nomination of Board of Director’s chairman |
| Result | Approved |
| Agenda | 3. Nomination of Board of Director's committeemembers |
| Result | Approved |
| Agenda | 4. Review of compensation for directors |
| Result | Approved |
| Agenda | 5. Approval of transactions with related parties |
| Result | Approved |
| Agenda | 6. Approval of investment for Plant 5 construction |
| Result | Approved |
|
FEB. 15, 2023 Attendance 5/6
|
|
|---|---|
| Agenda | (Reported) Operation status of internal control over financial reporting |
| Result | - |
| Agenda | (Reported) Assessment on internal control over financial reporting and audit report |
| Result | - |
| Agenda | (Reported) 2022 audit performance report |
| Result | - |
| Agenda | 1. Approval of amendments to internal control management |
| Result | Approved |
| Agenda | 2. Approval of convocation and objectives of general meetings of shareholders |
| Result | Approved |
|
JAN. 27, 2023 Attendance 6/6
|
|
|---|---|
| Agenda | (Reported) Progress on important matters |
| Result | - |
| Agenda | 1. Approval of FY2022 financial statements, annual business report, and 2023 business plan |
| Result | Approved |
| Agenda | 2. Approval of transactions with related parties |
| Result | Approved |
2022
| Date | Agenda | Result | Attendance |
|---|---|---|---|
| DEC. 21, 2022 | (Reported) FY2022 incentive payment plan report | - | 7/7 |
| 1. Approval of transactions with major shareholders | Approved | ||
| 2. Approval of transactions with related parties | Approved | ||
| NOV. 30, 2022 | 1. Approval of charitable contributions | Approved | 7/7 |
| 2. Approval of transactions with major shareholders | Approved | ||
| OCT. 26, 2022 | (Reported) Legal services fee for accounting issues litigation | - | 5/5 |
| OCT. 26, 2022 | (Reported) FY2022 3rd quarter earnings report | - | 7/7 |
| 1. Joining a financial instrument of Samsung Fire & Marine Insurance | Approved | ||
| 2. Approval of transactions with major shareholders | Approved | ||
| 3. Approval of anti-corruption guidelines | Approved | ||
| 4. Approval of charitable contributions | Approved | ||
| 5. Amendment to operational regulations of ESG Committee | Approved | ||
| JUL. 27, 2022 | (Reported) FY2022 half year earnings report | - | 7/7 |
| (Reported) Progress of important matters | - | ||
| 1. Approval of implementation of Anti-bribery management systems (ISO37001) | Approved | ||
| 2. Approval of transactions with major shareholders | Approved | ||
| 3. Approval of transactions with related parties | Approved | ||
| APR. 27, 2022 | (Reported) FY2022 1st quarter earnings report | - | 7/7 |
| (Reported) Progress of important matters | - | ||
| 1. Approval of transactions with related parties | Approved | ||
| 2. Approval of transactions with major shareholders | Approved | ||
| MAR. 29, 2022 | (Reported) Appointment of members of committees within the BOD | Approved | 7/7 |
| 1. Setting the remuneration of Directors | Approved | ||
| 2. Approval of contract to purchase land for Bio Campus II | Approved | ||
| 3. Approval of 2022 Safety and Health management system | Approved | ||
| FEB. 25, 2022 | (Reported) FY2021 Audit Committee activities | - | 7/7 |
| (Reported) Operation status of internal accounting management system | - | ||
| (Reported) Evaluation and audit report of internal accounting management system | - | ||
| (Reported) FY2021 Audit performance report | - | ||
| (Reported) Approval of payment of legal services fee for management’s litigation | - | ||
| (Reported) Assignment of employee stock ownership | - | ||
| 1. Decision to convene the 11th(FY2021) AGM | Approved | ||
| JAN. 28, 2022 | 1. Signed stock purchase agreement | Approved | 7/7 |
| 2. Paid-in capital increase | Approved | ||
| JAN. 27, 2022 | 1. Cancellation of signed stock purchase agreement and paid-in capital increase resolution | Approved | 5/7 |
| JAN. 27, 2022 | 1. Signed stock purchase agreement | Approved | 7/7 |
| 2. Paid-in capital increase | Approved | ||
| JAN. 24, 2022 | (Reported) Report of shareholders' dividend policy | - | 7/7 |
| 1. Approval of FY2021 financial statements and annual business report | Approved | ||
| 2. Approval of transactions with related parties | Approved | ||
| 3. Approval of charitable contribution of idle raw materials | Approved |
|
DEC. 21 2022 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) FY2022 incentive payment plan report |
| Result | - |
| Agenda | 1. Approval of transactions with major shareholders |
| Result | Approved |
| Agenda | 2. Approval of transactions with related parties |
| Result | Approved |
|
NOV. 30 2022 Attendance 7/7
|
|
|---|---|
| Agenda | 1. Approval of charitable contributions |
| Result | Approved |
| Agenda | 2. Approval of transactions with major shareholders |
| Result | Approved |
|
OCT. 26 2022 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported) Legal services fee for accounting issues litigation |
| Result | - |
|
OCT. 26 2022 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) FY2022 3rd quarter earnings report |
| Result | - |
| Agenda | 1. Joining a financial instrument of Samsung Fire & Marine Insurance |
| Result | Approved |
| Agenda | 2. Approval of transactions with major shareholders |
| Result | Approved |
| Agenda | 3. Approval of anti-corruption guidelines |
| Result | Approved |
| Agenda | 4. Approval of charitable contributions |
| Result | Approved |
| Agenda | 5. Amendment to operational regulations of ESG Committee |
| Result | Approved |
|
JUL. 27 2022 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) FY2022 half year earnings report |
| Result | - |
| Agenda | (Reported) Progress of important matters |
| Result | - |
| Agenda | 1. Approval of implementation of Anti-bribery management systems (ISO37001) |
| Result | Approved |
| Agenda | 2. Approval of transactions with major shareholders |
| Result | Approved |
| Agenda | 3. Approval of transactions with related parties |
| Result | Approved |
|
APR. 27 2022 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) FY2022 1st quarter earnings report |
| Result | - |
| Agenda | (Reported) Progress of important matters |
| Result | - |
| Agenda | 1. Approval of transactions with related parties |
| Result | Approved |
| Agenda | 2. Approval of transactions with major shareholders |
| Result | Approved |
|
MAR. 29, 2022 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) Appointment of members of committees within the BOD |
| Result | Approved |
| Result | Approved |
| Agenda | 1. Setting the remuneration of Directors |
| Result | Approved |
| Agenda | 2. Approval of contract to purchase land for Bio Campus II |
| Result | Approved |
| Agenda | 3. Approval of 2022 Safety and Health management system |
| Result | Approved |
|
FEB. 25, 2022 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) FY2021 Audit Committee activities |
| Result | - |
| Agenda | (Reported) Operation status of internal accounting management system |
| Result | - |
| Agenda | (Reported) Evaluation and audit report of internal accounting management system |
| Result | - |
| Agenda | (Reported) FY2021 Audit performance report |
| Result | - |
| Agenda | (Reported) Approval of payment of legal services fee for management’s litigation |
| Result | - |
| Agenda | (Reported) Assignment of employee stock ownership |
| Result | - |
| Agenda | 1. Decision to convene the 11th(FY2021) AGM |
| Result | Approved |
|
JAN. 28, 2022 Attendance 7/7
|
|
|---|---|
| Agenda | 1. Signed stock purchase agreement |
| Result | Approved |
| Agenda | 2. Paid-in capital increase |
| Result | Approved |
|
JAN. 27, 2022 Attendance 5/7
|
|
|---|---|
| Agenda | 1. Cancellation of signed stock purchase agreement and paid-in capital increase resolution |
| Result | Approved |
|
JAN. 27, 2022 Attendance 7/7
|
|
|---|---|
| Agenda | 1. Signed stock purchase agreement |
| Result | Approved |
| Agenda | 2. Paid-in capital increase |
| Result | Approved |
|
JAN. 24, 2022 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) Report of shareholders' dividend policy |
| Result | - |
| Agenda | 1. Approval of FY2021 financial statements and annual business report |
| Result | Approved |
| Agenda | 2. Approval of transactions with related parties |
| Result | Approved |
| Agenda | 3. Approval of charitable contribution of idle raw materials |
| Result | Approved |
2021
| Date | Agenda | Result | Attendance |
|---|---|---|---|
| DEC. 20, 2021 | (Reported) FY2021 incentive payment plan report | - | 7/7 |
| 1. Approval of transactions with related parties | Approved | ||
| 2. Approval of transactions with major shareholders | Approved | ||
| 3. Amendment to operational regulations of Related Party Transaction Committee | Approved | ||
| OCT. 26, 2021 | (Reported) FY2021 3rd quarter earnings report | - | 6/7 |
| 1. Approval of transactions with major shareholders | Approved | ||
| 2. Approval of transactions with related parties | Approved | ||
| 3. Approval of charitable contributions | Approved | ||
| JUL. 27, 2021 | (Reported) Legal service fee for management's litigation | - | 5/5 |
| JUL. 27, 2021 | (Reported) FY2021 half year earnings report | - | 7/7 |
| 1. Amendment to operational regulations of Audit Committee | Approved | ||
| 2. Amendment to instructions of internal accounting management | Approved | ||
| 3. Joining new technology investment association | Approved | ||
| 4. Issuance of Corporate bond | Approved | ||
| 5. Approval of 2021 charitable contributions | Approved | ||
| APR. 28, 2021 | (Reported) FY2021 1st quarter earnings report | - | 7/7 |
| 1. Constitution of ESG Committee | Approved | ||
| MAR. 19, 2021 | (Reported) 2021 incentive compensation plan | - | 7/7 |
| (Reported) Assessment of internal accounting management system by CEO and the Audit committee | - | ||
| (Reported) Assessment of 2020 compliance review | - | ||
| 1. Approval of 2021 compensation limit for Directiors | Approved | ||
| 2. Approval of transaction with major shareholders | Approved | ||
| MAR. 19, 2021 | 1. Approval of payment of legal services fee for management's litigation | - | 5/7 |
| FEB. 26, 2021 | (Reported) Operation status of internal accounting management system | - | 7/7 |
| (Reported) Evaluation and audit report of internal accounting management system | - | ||
| 1. Payment of Samsung CI License | Approved | ||
| 2. Transaction of Golf Club membership with an affiliate company | Approved | ||
| 3. Amendment to operational regulations of Remuneration Committee | Approved | ||
| 4. Approval of establishment of operation of ESG committee | Approved | ||
| 5. Decision to convene the 10th(FY2020) AGM | Approved | ||
| 6. Adoption of electronic voting system | Approved | ||
| 7. Approval of 2021 Safety and Health management system | Approved | ||
| FEB. 26, 2021 | 1. Change of limit on legal services fee for management's litigation | Approved | 5/7 |
| 2. Approval of change of members of Management Committee | Approved | ||
| JAN. 26, 2021 | 1. Approval of FY2020 financial statements and annual business report | Approved | 7/7 |
| 2. Approval of operational improvement strategies of Remuneration Committee | Approved | ||
| 3. Approval of concurrent positions of the Chief Executive Officer | Approved | ||
| JAN. 26, 2021 | 1. Approval of payment of legal services fee for management's litigation | Approved | 5/7 |
|
DEC. 20, 2021 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) FY2021 incentive payment plan report |
| Result | - |
| Agenda | 1. Approval of transactions with related parties |
| Result | Approved |
| Agenda | 2. Approval of transactions with major shareholders |
| Result | Approved |
| Agenda | 3. Amendment to operational regulations of Related Party Transaction Committee |
| Result | Approved |
|
OCT. 26, 2021 Attendance 6/7
|
|
|---|---|
| Agenda | (Reported) FY2021 3rd quarter earnings report |
| Result | - |
| Agenda | 1. Approval of transactions with major shareholders |
| Result | Approved |
| Agenda | 2. Approval of transactions with related parties |
| Result | Approved |
| Agenda | 3. Approval of charitable contributions |
| Result | Approved |
|
JUL. 27, 2021 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported) Legal service fee for management's litigation |
| Result | - |
|
JUL. 27, 2021 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) FY2021 half year earnings report |
| Result | - |
| Agenda | 1. Amendment to operational regulations of Audit Committee |
| Result | Approved |
| Agenda | 2. Amendment to instructions of internal accounting management |
| Result | Approved |
| Agenda | 3. Joining new technology investment association |
| Result | Approved |
| Agenda | 4. Issuance of Corporate bond |
| Result | Approved |
| Agenda | 5. Approval of 2021 charitable contributions |
| Result | Approved |
|
APR. 28, 2021 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) FY2021 1st quarter earnings report |
| Result | - |
| Agenda | 1. Constitution of ESG Committee |
| Result | Approved |
|
MAR. 19, 2021 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) 2021 incentive compensation plan |
| Result | - |
| Agenda | (Reported) Assessment of internal accounting management system by CEO and the Audit committee |
| Result | - |
| Agenda | (Reported) Assessment of 2020 compliance review |
| Result | - |
| Agenda | 1. Approval of 2021 compensation limit for Directiors |
| Result | Approved |
| Agenda | 2. Approval of transaction with major shareholders |
| Result | Approved |
|
MAR. 19, 2021 Attendance 5/7
|
|
|---|---|
| Agenda | 1. Approval of payment of legal services fee for management's litigation |
| Result | Approved |
|
FEB. 26, 2021 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) Operation status of internal accounting management system |
| Result | - |
| Agenda | (Reported) Evaluation and audit report of internal accounting management system |
| Result | - |
| Agenda | 1. Payment of Samsung CI License |
| Result | Approved |
| Agenda | 2. Transaction of Golf Club membership with an affiliate company |
| Result | Approved |
| Agenda | 3. Amendment to operational regulations of Remuneration Committee |
| Result | Approved |
| Agenda | 4. Approval of establishment of operation of ESG committee |
| Result | Approved |
| Agenda | 5. Decision to convene the 10th(FY2020) AGM |
| Result | Approved |
| Agenda | 6. Adoption of electronic voting system |
| Result | Approved |
| Agenda | 7. Approval of 2021 Safety and Health management system |
| Result | Approved |
|
FEB. 26, 2021 Attendance 5/7
|
|
|---|---|
| Agenda | 1. Change of limit on legal services fee for management's litigation |
| Result | Approved |
| Agenda | 2. Approval of change of members of Management Committee |
| Result | Approved |
|
JAN. 26, 2021 Attendance 7/7
|
|
|---|---|
| Agenda | 1. Approval of FY2020 financial statements and annual business report |
| Result | Approved |
| Agenda | 2. Approval of operational improvement strategies of Remuneration Committee |
| Result | Approved |
| Agenda | 3. Approval of concurrent positions of the Chief Executive Officer |
| Result | Approved |
|
JAN. 26, 2021 Attendance 5/7
|
|
|---|---|
| Agenda | 1. Approval of payment of legal services fee for management's litigation |
| Result | Approved |
2020
| Date | Agenda | Result | Attendance |
|---|---|---|---|
| DEC. 29, 2020 | (Reported) Report on operational improvement strategies of Remuneration Committee | - | 5/7 |
| 1. Approval of legal fee payment for a lawsuit against management | Approved | ||
| 2. Amendment to operational regulations of the Board of Directors (Introduction and operation of support staffs) | Approved | ||
| DEC. 16, 2020 | (Reported) FY2021 business plan report | - | 7/7 |
| (Reported) FY2020 incentive payment plan report | - | ||
| 1. Approval of transactions with major shareholders | Approved | ||
| 2. Approval of transactions with related parties | Approved | ||
| 3. Joining a financial instrument of Samsung Securities | Approved | ||
| 4. Payment of retirement pension | Approved | ||
| 5. Charitable contributions | Approved | ||
| 6. Appointment of Chief Executive Officer | Approved | ||
| OCT. 21, 2020 | (Reported) FY2020 3rd quarter earnings report | - | 7/7 |
| 1. Approval of transactions with major shareholders | Approved | ||
| 2. Approval of transactions with related parties | Approved | ||
| 3. Amendment to operational regulations and instructions of internal accounting management | Approved | ||
| 4. Appointment of compliance manager | Approved | ||
| SEP. 25, 2020 | (Reported) Report on progress regarding prosecution of executive | - | 7/7 |
| AUG. 11, 2020 | 1. Approval of investment in Plant 4 | Approved | 7/7 |
| JUL. 21, 2020 | (Reported) FY2020 half year earnings report | - | 7/7 |
| (Reported) FY2020 1H company's evaluation result | - | ||
| (Reported) Report on management issue | - | ||
| (Reported) 2020 July executive appointment | Approved | ||
| 1. Approval of transactions with major shareholder (Samsung Electronics) | Approved | ||
| 2. Joining a financial instrument of Samsung Securities | Approved | ||
| APR. 20, 2020 | (Reported) FY2020 1st quarter earnings report | - | 7/7 |
| MAR. 20, 2020 | (Reported) 2020 incentive payment report | - | 7/7 |
| (Reported) Report of new facility investment | - | ||
| 1. Appointment of CEO & director | Approved | ||
| 2. Appointment of Chairman of BOD | Approved | ||
| 3. Appointment of members of committees within the BOD | Approved | ||
| 4. Setting the remuneration of directors | Approved | ||
| 5. Approval of large-scale internal transactions | Approved | ||
| FEB. 28, 2020 | (Reported) Reporting the operation status of internal accounting management system | - | 5/5 |
| (Reported) Evaluation and audit report of the internal accounting management system | - | ||
| (Reported) Evaluation and report of compliance | - | ||
| (Reported) Report of major facility supplementary investment | - | ||
| 1. Decision to convene the 9th (FY2019) AGM | Approved | ||
| JAN. 22, 2020 | 1. Approval of FY2019 financial statements and annual business report | Approved | 5/5 |
| JAN. 10, 2020 | 1. Approval of the establishment of a foreign corporation in the U.S. | Approved | 5/5 |
|
DEC. 29, 2020 Attendance 5/7
|
|
|---|---|
| Agenda | (Reported) Report on operational improvement strategies of Remuneration Committee |
| Result | - |
| Agenda | 1. Approval of legal fee payment for a lawsuit against management |
| Result | Approved |
| Agenda | 2. Amendment to operational regulations of the Board of Directors (Introduction and operation of support staffs) |
| Result | Approved |
|
DEC. 16, 2020 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) FY2021 business plan report |
| Result | - |
| Agenda | (Reported) FY2020 incentive payment plan report |
| Result | - |
| Agenda | 1. Approval of transactions with major shareholders |
| Result | Approved |
| Agenda | 2. Approval of transactions with related parties |
| Result | Approved |
| Agenda | 3. Joining a financial instrument of Samsung Securities |
| Result | Approved |
| Agenda | 4. Payment of retirement pension |
| Result | Approved |
| Agenda | 5. Charitable contributions |
| Result | Approved |
| Agenda | 6. Appointment of Chief Executive Officer |
| Result | Approved |
|
OCT. 21, 2020 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) FY2020 3rd quarter earnings report |
| Result | - |
| Agenda | 1. Approval of transactions with major shareholders |
| Result | Approved |
| Agenda | 2. Approval of transactions with related parties |
| Result | Approved |
| Agenda | 3. Amendment to operational regulations and instructions of internal accounting management |
| Result | Approved |
| Agenda | 4. Appointment of compliance manager |
| Result | Approved |
|
SEP. 25, 2020 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) Report on progress regarding prosecution of executive |
| Result | - |
|
AUG. 11, 2020 Attendance 7/7
|
|
|---|---|
| Agenda | 1. Approval of investment in Plant 4 |
| Result | Approved |
|
JUL. 21, 2020 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) FY2020 half year earnings report |
| Result | - |
| Agenda | (Reported) FY2020 1H company's evaluation result |
| Result | - |
| Agenda | (Reported) Report on management issue |
| Result | - |
| Agenda | (Reported) 2020 July executive appointment |
| Result | - |
| Agenda | 1. Approval of transactions with major shareholder (Samsung Electronics) |
| Result | Approved |
| Agenda | 2. Joining a financial instrument of Samsung Securities |
| Result | Approved |
|
APR. 20, 2020 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) FY2020 1st quarter earnings report |
| Result | - |
|
MAR. 20, 2020 Attendance 7/7
|
|
|---|---|
| Agenda | (Reported) 2020 incentive payment report |
| Result | - |
| Agenda | (Reported) Report of new facility investment |
| Result | - |
| Agenda | 1. Appointment of CEO & director |
| Result | Approved |
| Agenda | 2. Appointment of Chairman of BOD |
| Result | Approved |
| Agenda | 3. Appointment of members of committees within the BOD |
| Result | Approved |
| Agenda | 4. Setting the remuneration of directors |
| Result | Approved |
| Agenda | 5. Approval of large-scale internal transactions |
| Result | Approved |
|
FEB. 28, 2020 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported) Reporting the operation status of internal accounting management system |
| Result | - |
| Agenda | (Reported) Evaluation and audit report of the internal accounting management system |
| Result | - |
| Agenda | (Reported) Evaluation and report of compliance |
| Result | - |
| Agenda | (Reported) Report of major facility supplementary investment |
| Result | - |
| Agenda | 1. Decision to convene the 9th (FY2019) AGM |
| Result | Approved |
|
JAN. 22, 2020 Attendance 5/5
|
|
|---|---|
| Agenda | 1. Approval of FY2019 financial statements and annual business report |
| Result | Approved |
|
JAN. 11, 2020 Attendance 5/5
|
|
|---|---|
| Agenda | 1. Approval of the establishment of a foreign corporation in the U.S. |
| Result | Approved |
2019
| Date | Agenda | Result | Attendance |
|---|---|---|---|
| DEC. 16, 2019 | (Reported) FY2019 Incentive payment status | - | 5/5 |
| 1. Approval of transactions with major shareholder | Approved | ||
| 2. Approval of transactions with related parties | Approved | ||
| 3. Joining a financial instrument of Samsung Securities | Approved | ||
| 4. Payment of retirement pension | Approved | ||
| OCT. 23, 2019 | (Reported) FY2019 3Q earnings report | - | 5/5 |
| SEP. 11, 2019 | (Reported) Discussions on the creation of a support organization in the Audit Committee | - | 5/5 |
| JUL. 23, 2019 | (Reported) FY2019 half year earnings report | - | 5/5 |
| 1. Approval of FY2018 financial statements corrections | - | ||
| APR. 24, 2019 | (Reported) FY2019 1st quarter earnings report | - | 5/5 |
| 1. Approval of transactions with related parties | Approved | ||
| MAR. 22, 2019 | 1. Appointment of members of committees within the BOD | Approved | 5/5 |
| 2. Setting the remuneration of directors | Approved | ||
| 3. Joining a financial instrument of Samsung Securities | Approved | ||
| 4. Approval of transactions with related parties | Approved | ||
| FEB. 27, 2019 | (Report) Reporting the operation status of internal accounting management system | - | 5/5 |
| (Report) Evaluation and audit report of the internal accounting management system | - | ||
| (Report) 2019 Incentive Payment Report | - | ||
| (Report) Evaluation and report of 2018 Compliance | - | ||
| 1. Decision to convene the 8th(FY2018) AGM | - | ||
| JAN. 31, 2019 | 1. Approval of FY2018 financial statements and annual business report | - | 5/5 |
| 2. Approval of revision of the operation regulations of audit committee | Approved | ||
| 3. Approval of revision of internal accounting control system regulations | Approved | ||
| 4. Addition of New Business Place | Approved | ||
| 5. Approval of transactions with major shareholders | Approved |
|
DEC. 16, 2019 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported) FY2019 Incentive payment status |
| Result | - |
| Agenda | 1. Approval of transactions with major shareholder |
| Result | Approved |
| Agenda | 2. Approval of transactions with related parties |
| Result | Approved |
| Agenda | 3. Joining a financial instrument of Samsung Securities |
| Result | Approved |
| Agenda | 4. Payment of retirement pension |
| Result | Approved |
|
OCT. 23, 2019 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported) FY2019 3Q earnings report |
|
SEP. 11, 2019 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported) Discussions on the creation of a support organization in the Audit Committee |
| Result | - |
|
JUL. 23, 2019 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported) FY2019 half year earnings report |
| Result | - |
| Agenda | 1. Approval of FY2018 financial statements corrections |
| Result | - |
|
APR. 24, 2019 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported) FY2019 1st quarter earnings report |
| Result | - |
| Agenda | 1. Approval of transactions with related parties |
| Result | Approved |
|
MAR. 22, 2019 Attendance 5/5
|
|
|---|---|
| Agenda | 1. Appointment of members of committees within the BOD |
| Result | Approved |
| Agenda | 2. Setting the remuneration of directors |
| Result | Approved |
| Agenda | 3. Joining a financial instrument of Samsung Securities |
| Result | Approved |
| Agenda | 4. Approval of transactions with related parties |
| Result | Approved |
|
FEB. 27, 2019 Attendance 5/5
|
|
|---|---|
| Agenda | (Report) Reporting the operation status of internal accounting management system |
| Result | - |
| Agenda | (Report) Evaluation and audit report of the internal accounting management system |
| Result | - |
| Agenda | (Report) 2019 Incentive Payment Report |
| Result | - |
| Agenda | (Report) Evaluation and report of 2018 Compliance |
| Result | - |
| Agenda | 1. Decision to convene the 8th(FY2018) AGM |
| Result | Approved |
|
JAN. 31, 2019 Attendance 5/5
|
|
|---|---|
| Agenda | 1. Approval of FY2018 financial statements and annual business report |
| Result | Approved |
| Agenda | 2. Approval of revision of the operation regulations of audit committee |
| Result | Approved |
| Agenda | 3. Approval of revision of internal accounting control system regulations |
| Result | Approved |
| Agenda | 4. Addition of New Business Place |
| Result | Approved |
| Agenda | 5. Approval of transactions with major shareholders |
| Result | Approved |
2018
| Date | Agenda | Result | Attendance |
|---|---|---|---|
| DEC. 24, 2018 | 1. Approval of transactions with major shareholders | Approved | 5/5 |
| 2. Approval of transactions with related parties | Approved | ||
| 3. Payment of retirement pension | Approved | ||
| 4. Revision of the in-house trade committee’s operation provisions | Approved | ||
| OCT. 23, 2018 | (Reported Item) FY2018 3rd quarter earnings report | - | 5/5 |
| 1. Time deposits of Samsung Securities Co., Ltd. | Approved | ||
| 2. Investments in subsidiaries | Approved | ||
| OCT. 04, 2018 | (Reported Item) Report on Major Management Issues | - | 5/5 |
| JUL. 23, 2018 | (Reported Item) FY2018 1st half year earnings report | - | 5/5 |
| JUN. 28, 2018 | (Reported Item) Report on Major Management Issues | - | 5/5 |
| APR. 24, 2018 | (Reported Item) FY2018 1st quarter earnings report | - | 5/5 |
| 1. Issue of Corporate bond | Approved | ||
| 2. Approval of trading with controlling shareholder | Approved | ||
| MAR. 22, 2018 | 1. Setting the remuneration of directors | Approved | 5/5 |
| FEB. 28, 2018 | (Reported Item) Report on the internal accounting management system | - | 5/5 |
| 1. Approval of FY2017 financial statements and annual business report | Approved | ||
| 2. Decision to convene the 7th(FY2017) AGM | Approved | ||
| JAN. 31, 2018 | (Reported Item) Performance bonus of FY2017 for key objectives | - | 5/5 |
| 1. Approval of FY2017 financial statements and annual business report | Approved | ||
| 2. Revision of the operation regulations of the independent director referral committee | Approved |
|
DEC. 24, 2018 Attendance 5/5
|
|
|---|---|
| Agenda | 1. Approval of transactions with major shareholders |
| Result | Approved |
| Agenda | 2. Approval of transactions with related parties |
| Result | Approved |
| Agenda | 3. Payment of retirement pension |
| Result | Approved |
| Agenda | 4. Revision of the in-house trade committee’s operation provisions |
| Result | Approved |
|
OCT. 23, 2018 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported Item) FY2018 3rd quarter earnings report |
| Result | - |
| Agenda | 1. Time deposits of Samsung Securities Co., Ltd. |
| Result | Approved |
| Agenda | 2. Investments in subsidiaries |
| Result | Approved |
|
OCT. 04, 2018 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported Item) Report on Major Management Issues |
| Result | - |
|
JUL. 23, 2018 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported Item) FY2018 1st half year earnings report |
| Result | - |
|
JUL. 28, 2018 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported Item) Report on Major Management Issues |
| Result | - |
|
APR. 24, 2018 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported Item) FY2018 1st quarter earnings report |
| Result | - |
| Agenda | 1. Issue of Corporate bond |
| Result | Approved |
| Agenda | 2. Approval of trading with controlling shareholder |
| Result | Approved |
|
MAR. 22, 2018 Attendance 5/5
|
|
|---|---|
| Agenda | 1. Setting the remuneration of directors |
| Result | Approved |
|
FEB. 28, 2018 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported Item) Report on the internal accounting management system |
| Result | - |
| Agenda | 1. Approval of FY2017 financial statements and annual business report |
| Result | Approved |
| Agenda | 2. Decision to convene the 7th(FY2017) AGM |
| Result | Approved |
|
JAN. 31, 2018 Attendance 5/5
|
|
|---|---|
| Agenda | (Reported Item) Performance bonus of FY2017 for key objectives |
| Result | - |
| Agenda | 1. Approval of FY2017 financial statements and annual business report |
| Result | Approved |
| Agenda | 2. Revision of the operation regulations of the independent director referral committee |
| Result | Approved |
2017
| Date | Agenda | Result | Attendance |
|---|---|---|---|
| JUL. 24, 2017 | Report on financial results concerning 2Q/2017 | - | 5/5 |
| 1. Approval of transactions with major shareholders | Approved | ||
| JUL. 30, 2017 | Report on result of corporate appraisal of the company in the first half of 2017 | - | 5/5 |
| MAY. 18, 2017 | Report on status of operation of the company’s evaluation/remuneration system | - | 5/5 |
| 1. Approval of transactions with major shareholders | Approved | ||
| APR. 25, 2017 | Report on financial results concerning 1Q/2017 | - | 5/5 |
| MAR. 24, 2017 | 1. Election of the representative director and entrustment of business to directors | Approved | 5/5 |
| 2. Appointment of the chairperson of the board of directors | Approved | ||
| 3. Appointment of members of the committees of the board of directors | Approved | ||
| 4. Execution of limit of directors’ remuneration | Approved | ||
| 5. Revision of the rules and regulations of the board of directors | Approved | ||
| FEB. 27, 2017 | 1. Convening of the general meeting of shareholders and decision on purpose of the meeting | Approved | 5/5 |
| 2. Approval of transactions with major shareholders | Approved | ||
| JAN. 24, 2017 | 1. Convening of the general meeting of shareholders and decision on purpose of the meeting | Approved | 5/5 |
|
JUL. 24, 2017 Attendance 5/5
|
|
|---|---|
| Agenda | Report on financial results concerning 2Q/2017 |
| Result | - |
| Agenda | 1. Approval of transactions with major shareholders |
| Result | Approved |
|
JUL. 30, 2017 Attendance 5/5
|
|
|---|---|
| Agenda | Report on result of corporate appraisal of the company in the first half of 2017 |
| Result | - |
|
MAY. 18, 2017 Attendance 5/5
|
|
|---|---|
| Agenda | Report on status of operation of the company’s evaluation/remuneration system |
| Result | - |
| Agenda | 1. Approval of transactions with major shareholders |
| Result | Approved |
|
APR. 25, 2017 Attendance 5/5
|
|
|---|---|
| Agenda | Report on financial results concerning 1Q/2017 |
| Result | - |
|
MAR. 24, 2017 Attendance 5/5
|
|
|---|---|
| Agenda | 1. Election of the representative director and entrustment of business to directors |
| Result | Approved |
| Agenda | 2. Appointment of the chairperson of the board of directors |
| Result | Approved |
| Agenda | 3. Appointment of members of the committees of the board of directors |
| Result | Approved |
| Agenda | 4. Execution of limit of directors’ remuneration |
| Result | Approved |
| Agenda | 5. Revision of the rules and regulations of the board of directors |
| Result | Approved |
|
FEB. 27, 2017 Attendance 5/5
|
|
|---|---|
| Agenda | 1. Convening of the general meeting of shareholders and decision on purpose of the meeting |
| Result | Approved |
| Agenda | 2. Approval of transactions with major shareholders |
| Result | Approved |
|
JAN. 24, 2017 Attendance 5/5
|
|
|---|---|
| Agenda | 1. Convening of the general meeting of shareholders and decision on purpose of the meeting |
| Result | Approved |
2016
| Date | Agenda | Result | Attendance |
|---|---|---|---|
| DEC. 13, 2016 | 1. Participation in Samsung Bioepis’ capital increase | Approved | 5/5 |
| 2. Participation in Archigen’s capital increase | Approved | ||
| 3. Approval of transactions with major shareholders | Approved | ||
| 4. Approval of transactions with specially related parties | Approved | ||
| 5. Subscription to retirement pension | Approved | ||
| SEP. 29, 2016 | 1. Approval for issuance of new shares for IPO and for sales of old shares | Approved | 5/5 |
| 2. Approval of internal trading with specially related parties | Approved | ||
| AUG. 10, 2016 | 1. Appointment of the chairperson of the board of directors | Approved | 5/5 |
| 2. Entrusting business to directors | Approved | ||
| 3. Appointment of the members of the committees of the board of directors | Approved | ||
| 4. Appointment of the compliance officer | Approved | ||
| 5. Appointment of the transfer agent | Approved |
|
DEC. 13, 2016 Attendance 5/5
|
|
|---|---|
| Agenda | 1. Participation in Samsung Bioepis’ capital increase |
| Result | Approved |
| Agenda | 2. Participation in Archigen’s capital increase |
| Result | Approved |
| Agenda | 3. Approval of transactions with major shareholders |
| Result | Approved |
| Agenda | 4. Approval of transactions with specially related parties |
| Result | Approved |
| Agenda | 5. Subscription to retirement pension |
| Result | Approved |
|
SEP. 29, 2016 Attendance 5/5
|
|
|---|---|
| Agenda | 1. Approval for issuance of new shares for IPO and for sales of old shares |
| Result | Approved |
| Agenda | 2. Approval of internal trading with specially related parties |
| Result | Approved |
|
AUG. 10, 2016 Attendance 5/5
|
|
|---|---|
| Agenda | 1. Appointment of the chairperson of the board of directors |
| Result | Approved |
| Agenda | 2. Entrusting business to directors |
| Result | Approved |
| Agenda | 3. Appointment of the members of the committees of the board of directors |
| Result | Approved |
| Agenda | 4. Appointment of the compliance officer |
| Result | Approved |
| Agenda | 5. Appointment of the transfer agent |
| Result | Approved |